000			02132 a2200577 4500
005			20250516184821.0
264		0	_c20150205
008			201502s 0 0 eng d
022			_a1532-866X
024	7		_a10.1016/j.semarthrit.2013.11.007 _2doi
040			_aNLM _beng _cNLM
100	1		_aFanouriakis, Antonis
245	0	0	_aCoexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history. _h[electronic resource]
260			_bSeminars in arthritis and rheumatism _cJun 2014
300			_a751-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdrenal Cortex Hormones _xtherapeutic use
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use
650	0	4	_aAntirheumatic Agents _xtherapeutic use
650	0	4	_aAzathioprine _xtherapeutic use
650	0	4	_aComorbidity
650	0	4	_aFemale
650	0	4	_aGlatiramer Acetate
650	0	4	_aGreece _xepidemiology
650	0	4	_aHumans
650	0	4	_aHydroxychloroquine _xtherapeutic use
650	0	4	_aImmunologic Factors _xtherapeutic use
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInterferon-beta _xtherapeutic use
650	0	4	_aLupus Erythematosus, Systemic _xdrug therapy
650	0	4	_aMale
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Sclerosis _xdrug therapy
650	0	4	_aNatalizumab
650	0	4	_aPeptides _xtherapeutic use
650	0	4	_aPrevalence
650	0	4	_aRituximab
700	1		_aMastorodemos, Vasileios
700	1		_aPamfil, Cristina
700	1		_aPapadaki, Efrosini
700	1		_aSidiropoulos, Prodromos
700	1		_aPlaitakis, Andreas
700	1		_aAmoiridis, George
700	1		_aBertsias, George
700	1		_aBoumpas, Dimitrios T
773	0		_tSeminars in arthritis and rheumatism _gvol. 43 _gno. 6 _gp. 751-8
856	4	0	_uhttps://doi.org/10.1016/j.semarthrit.2013.11.007 _zAvailable from publisher's website
999			_c23361276 _d23361276